GI - Peptic ulcer, Gallstones, Pancreatitis Flashcards

1
Q

Ddx GI causes of epigastric pain

A

Gastroduodenal

  • Peptic ulcer
  • Atypical GERD
  • Gastric cancer

Hepatobiliary:

  • Pancreatitis
  • Gallstones
  • Pancreatic cancer

Functional dyspepsia (*60%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ddx non-GI causes of epigastric pain

A

Cardiac: MI, myocarditis, ACS…etc

Chest: Pneumothorax, PE…etc

Haematological: Acute leukaemia, hemolytic anaemia..etc

Metabolic: Uremia, DM, porphyria, Addision’s

Toxin: lead poisoning, hypersensitivity

Infections: Herpes zoster (shingles)

Neurological: radiculitis, tabes dorsalis

Misc: muscular contusion, narcotic withdrawal, psychiatric disorders..etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Differentiate the likely organs involved in constant vs Colicky vs episodic/ plateau epigastric pain

A

Constant moderate pain - likely ulcers

Colicky - likely intestinal or renal colic

Episodic/ plateau - likely biliary colic/ pancreatic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ddx acute epigastric pain radiating to back

A

Biliary pain
Acute pancreatitis
Dissecting aortic aneurysm
Posteriorly penetrating PU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ddx epigastric pain with repeated vomiting

A

Food poisoning/ gastroenteritis
Acute pancreatitis
Gastric outlet obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ddx agonizing, generalized abdominal pain

A

Mesenteric thrombosis
Ischemic colitis
Peritonitis
Perforated acute pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alarming features of acute epigastric pain

A

Age: >45 years old

Constitutional symptoms: Anaemia/ bleeding, Unintentional weight loss, Anorexia, lymphadenopathy

Alarming S/S

  • Early satiety
  • Abdominal mass
  • Jaundice
  • Dysphagia or odynophagia
  • Persistent vomiting

PMH:

  • Upper GI cancer
  • Ulcers

Family history: upper GI cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Peptic ulcers

  • Specify possible locations of ulceration
A

Gastric ulcer (20%) - usu. at lesser curvature and corpus-antrum junction

Duodenal ulcer (75%) - usu. solitary D1 if no NSAID use

Esophageal ulcer

Merkel’s diverticulum (ectopic epithelium)

Anastomotic ulcer/ Stoma opening (gastroenterostomy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Peptic ulcer complications and S/S

A

Ulcer complications: ‘bleed’, ‘burst’, ‘block’ and ‘burrow’ (fistulization to other organs)

→ Bleeding: symptomatic UGIB, anaemia

→ Perforation: abrupt severe epigastric pain secondarily generalized, fever, shock

→ Gastric outlet obstruciton: nausea, vomiting (of old food >1h), epigastric distension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Peptic ulcer

- Aetiologies

A

H. pylori infection: 92% DU, 70% GU

NSAIDs: 5% DU, 25% GU

Stress, ICU setting esp if mechanical ventilation or coagulopathy

Zollinger-Ellison syndrome (gastrinoma, G cell hyperplasia)
→ Features: hypergastrinaemia + ulcers at atypical location

Smoking

Drugs: alcohol, antiplatelets, steroids

Crohn’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathogenesis of stress peptic ulcers

A

Stress ulcers are due to biliary reflux, uraemic toxins and impaired perfusion to stomach, leading to impairment of mucosal protection of stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

H. pylori

  • Pathophysiology of gastric mucosa inflammation
A

Pathology: Expresses certain cytotoxins to provoke gastritis in underlying epithelium

Antral gastritis (majority) → ↓somatostatin, ↑gastrin release → ↑acid production → DU ± GU

Pangastritis (minority, 1%) → chronic atrophic gastritis ± GU → hypochlorhydria → proliferation of other bacteria → mutagenic nitrites → ↑risk of CA stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

H.pylori

  • Gram stain, morphology
  • Survival mechanism in stomach
  • Transmission
  • Risk factors of infection
A

Bacteriology: G- bacilli, spiral w/ unipolar flagella
→ Resides in mucus layer overlying mucosa where pH is~7
→ Expresses urease to convert urea into ammonia + bicarbonate → counteract stomach acidity

Transmission: unknown, likely person-to-person contact via oro-oral or feco-oral route

RFs: unclean water supply, poor sanitary conditions, crowded environment, ↓socio-economic status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

H. pylori-associated diseases

A
Dyspepsia, 
chronic gastritis, 
PUD (GU/DU)
Gastric adenocarcinoma, MALT lymphoma
Extra-GI: anaemia (due to B12 or Fe def)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnostic tests for H. pylori infection

Which tests used for post-treatment monitoring

A

Invasive endoscopic tests: 3 biopsies at antrum/ proximal stomach

  • Rapid urease test (CLO test)
  • Biopsy for histology
  • Culture for S/T
Non-invasive: 
Whole blood/ serum test for antibodies (Specific IgG)
Urine antibody 
Stool antigen 
Urea breath test with C-13 isotope

Stool antigen and urea breath test are used for post-treatment monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanism of rapid urease test/ CLO test

A

Rapid urease test (CLO test): sens 90%, spec 95%

→ Bx sample added to a solution of urea + phenol red
→ urease-positive H. pylori will hydrolyze urea into NH3 + CO2
→ ↑pH turns phenol red from yellow to pink
→ usually read at 1h and 4h (85% will change colour ≤1h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment regimens of H. pylori infection

A

Triple therapy: PPI + amoxicillin + clarithromycin bi-daily ×7d

Bismuth quadruple therapy: PPI + bismuth + tetracycline + metronidazole

Non-bismuth quadruple therapy: PPI + amoxicillin + clarithromycin + Metronidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Indication for Bismuth-containing quadruple therapy

A

Dual clarithromycin and metronidazole resistance (>15%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Post H pylori treatment monitoring

A

NON-invasive tests, eg. stool antigen tests, urea breath tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pathogenesis of NSAID-related peptic ulcer

A

Pathology:

Impair gastric mucosa defense:

  • Block prostaglandin production
  • Block bi-carbonate and mucus production

> > Impair mucus layer, lowers pH and increase susceptibility of gastric acid and pepsin attack
pH dependent gastric mucosal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

NSAID-related peptic ulcer

Risk factors: patient factors and drug factors

A

Patient factors:

  • Age >60y
  • Hx of PUD or UGI complications

Drug-related factors:

  • ↑COX-1 selectivity
  • High dose or concurrent use
  • Concurrent anticoagulants or steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which NSAIDs cause most peptic ulcer

Which cause the least

A

Most PU:
Aspirin, Ketoprofen, Etodolac, Piroxicam

Least PU:
Fenoprofen, Diclofenac, Naproxen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prevention of NSAID-related peptic ulcer

A

Prevention:
→ Review meds: review indications for NSAIDs, consider switching to less ulcerogenic NSAIDs or COX-2 inhibitor

→ Prior H. pylori testing ± eradication

→ Co-therapy by PPI, H2 receptor antagonist, misoprostol (Prostaglandin analogue)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Prevention of aspirin related GI complications

A

H. pylori eradication

H2 receptor antagonist, PPI, Misoprostol use

Substitute aspirin with Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Clinical features of peptic ulcer Differentiating S/S between gastric ulcer and duodenal ulcers
Dyspepsia (80%): variable discomfort at epigastrium ± radiation - ulcer-like (burning/gnawing pain) or - dysmotility-like (bloating, early satiety, anorexia, nausea) Pain localizes to epigastrium, related to food and episodic GU vs DU: - GU is exacerbated by eating vs DU relieved by eating → corresponding weight changes - DU a/w pain at night and 2-3 hours after eating vs GU pain during eating
26
Diagnostic investigations of peptic ulcer disease Management plan of uncomplicated PUD
OGD with biopsy: - Diagnotic: Biopsy to confirm PUD, r/o malignancy, H. pylori testing - Therapeutic: stop ulcer bleeding Mx of underlying cause: → H. pylori eradication therapy as above → Avoid NSAIDs, stop smoking and limit alcohol intake Antisecretory therapy: PPI Re-scope at 6mo for GU to detect non-healing ulcers
27
Management plan of refractory/ complicated PUD
Surgical therapy for refractory or complicated ulcers: lower risk of malignancy → GU: ulcer excision, eg. partial gastrectomy + Bilroth I (or II) reconstruction → DU: acid-reducing procedures, eg. truncal vagotomy + pyloroplasty
28
Management of urgent peptic ulcer bleeding
IV PPI: bolus + maintenance → mandatory for any UGIB Endoscopic Treatments: e.g. hemoclip, heater probe...etc Angiography for transcatheter arterial embolization (TAE) Surgical Mx: - DU: duodenotomy with 3-point ligation of gastroduodenal a. - GU: plication + Bx vs partial gastrectomy + B1/2 reconstruction
29
Presentation of perforated PU
S/S: triad of → Sudden abdominal pain: - Epigastric onset, secondarily generalized - ± radiation to shoulder tip (diaphragm irritation) and RLQ (spillage into paracolic gutter) → ‘Board-like’ rigidity due to generalized peritonitis - Absent bowel sounds - ↓liver dullness due to free gas under diaphragm → Systemic upset: tachycardia, fever, tachypnoea, septic/hypovolemic shock
30
Investigations to confirm perforated PU
Pneumoperitoneum on imaging: - Erect CXR: free gas under peritoneum (≥50%) ± continuous diaphragm sign - AXR: ↑clarity of organ outlines, eg. double wall sign (Rigler sign) eg. falciform ligament sign eg. urachus sign eg. hepatic edge sign - USG for peritoneal stripe sign - CT for free gas or fluid in peritoneal cavity
31
Management of perforated PU
→ Prompt resuscitation + NPO + NGT suction → IV broad spectrum Abx, PPI and analgesics → Urgent OT: - GU: direct repair in young (↓risk of CA), partial gastrectomy + reconstruction in old - DU: omental patch repair60 ± acid-reducing procedure → Post-op eradication of cause, eg. PPI, HP eradication, NSAID avoidance
32
Ulcer-related gastric outlet obstruction Pathogenesis S/S Dx
Pathogenesis: spasm, oedema, pyloric dysmotility due to acute inflammation + fibrosis due to chronic inf’n >> gastric atony after prolonged GOO S/S: → Early satiety, bloating, indigestion, anorexia, weight loss → Nausea, vomiting (large quantities, characteristically of content 8-12h after eating) → Epigastric distension w/ succussion splash or visible peristalsis after eating → Electrolyte disturbance: dehydration (↑urea), hypoK, hypoCl metabolic alkalosis Approach: → Resuscitation + correction of electrolytes + NGT suction → OGD: Bx for underlying pathology (esp to exclude malignancy)
33
Gallstones - Define terms for stone in gallbladder, CBD, intrahepatic ducts - Define complicated vs uncomplicated gallstones disease
→ Cholecystolithiasis: stone in gallbladder → Choledocholithiasis: stone in the common bile duct → Hepatolithiasis: stones in intrahepatic bile ducts (i.e. RPC) → Uncomplicated gallstone disease: biliary colic w/o gallstone-related complications → Complicated gallstone ds: a/w gallstone-related complications, eg. acute cholecystitis, cholangitis, gallstone pancreatitis, gallstone ileus, Mirizzi syndrome
34
List 4 major types of gallstones, appearance and respective composition
1. Cholesterol - cholesterol monohydrate crystals; Yellow, fine granular, hard, faceted 2. Black Pigmented - calcium bilirubinate; Jet-black, hard, speculated and brittle 3. Brown Pigmented - calcium bilirubinate, palmitate, sterate with dead bacteria; Brown, softer, clay-like 4. Mixed (majority) - both cholesterol and calcium salts; ‘egg-shell’ appearance on plain XR films
35
Pathogenesis of cholesterol gallstones
Liver secretes cholesterol in vesicular form with phospholipids → dissolved in GB by bile salts into micelles → GB concentration of bile results in overwhelming of dissolving capacity of bile salts → supersaturation and crystallization
36
Risk factors of cholesterol gallstones
"Fat + Female + Fertile + Forty" 1. Excessive cholesterol secretion - Hormonal: multiparity, OCP - Metabolic: obesity, DM, ↑lipids 2. Gallbladder stasis - ↓enteric intake: aggressive weight reduction, NPO on TPN - Neurogenic: SCI, truncal vagotomy - Hormonal: pregnancy, OCP, HRT
37
Pathogenesis of black pigmented gallstones Risk factors
Stone formation requires unconjugated bilirubin which can come from (1) spillage from ↑haeme turnover [cause of black stones] (2) bile acid malabsorption Risk factors: 1. ↑haeme turnover Haemolysis: G6PD (commonest), cirrhosis-related hypersplenism, thalassaemia Gilbert syndrome 2. Bile acid malabsorption Ileal disease: resection, Crohn’s disease 3. GB stasis
38
Pathogenesis of brown pigmented gallstones Risk factors
Unconjugated bilirubin is formed within an infected biliary tree where there is bacterial β-glucuronidase Bacteria also hydrolyze phospoholipids to release FAs from fat vesicles → form calcium salts → accounts for softer texture Risk factors: 1. Bacterial infection of biliary tree 2. Strictures: parasitic-induced (RPC), prior ERCP strictures, malignancy 3. Other causes, eg. stents
39
Pathogenesis of mixed gallstone
Prior cholesterol stone causes stasis and bacterial colonization → deconjugation of bilirubin forming calcium bilirubinate component on top of cholesterol stone
40
Four stages of gallstone disease
41
Gallstone disease - Typical presentation - Complications
Typical presentation - Mostly asymptomatic, incidental finding - Biliary colic, nausea, vomiting, dyspepsia, fat intolerance Complications: GB: cholecystitis (± gangrene, empyema, perforation), CA GB, Mirizzi syndrome CBD: CBD stone, cholangitis Others: gallstone pancreatitis, gallstone ileus, pancreatitis
42
Gallstone disease - Pathophysiology of biliary colic - S/S (OPQRST)
Pathogenesis: impaction of gallstones or sludge in cystic duct during GB contraction → pain due to GB distension stereotypical attacks of upper abd pain after ingestion of fatty meal - Onset: begins quite suddenly and increases steadily over 10-20min - Precipitation: usually begins post-prandially, or at night - Quality: intense, dull pain - Region/radiation: occurs in epigastric region initially and may migrate to RUQ; may radiate to right scapular tip (Collin's sign) - Severity: intense, waxing-and-waning - Timing: usually lasts 1-5h
43
First-line investigations for gallstones
P/E + blood tests: should be normal AXR: for pigmented stones (cannot see cholesterol stones) Trans-abdominal US** - Stones: echogenic foci that casts an acoustic shadow - Sludge: heterogenous enhancement w/o shadow ERCP/PTBD: usually for therapeutic purposes Additional: EUS ± bile collection: identify small stones missed on TAUS esp CBD ones MRCP: usually as 2nd line if TAUS -ve
44
Indications for cholecystectomy
Asymptomatic gallstones Symptomatic or complicated gallstones risk of CA gallbladder, eg. GB polyp >0.5cm, porcelain gallbladder
45
Causes of acute pancreatitis
Idiopathic (15-25%) Gallstones (55%) Ethanol (35%): acute exacerbation of chronic alcoholism Trauma Steroids: ↑viscosity of pancreatic juice Mumps and other infections: → Viruses: mumps, coxsackievirus, hepatitis B, CMV, VZV, HSV, HIV → Bacterial: Mycoplasma, Legionella, Leptospira, Salmonella → Fungal: Aspergillus → Parasitic: Toxoplasma, Cryptosporidium, Ascaris Autoimmune: SLE, Sjogren’s syndrome, vasculitis (eg. PAN) Scorpion/ toxins, eg. organophosphate poisoning (cholinergic stimulation) Hypercalcaemia (3rd commonest) and Hypertriglyceridaemia (4th) ERCP-related (2-5%) Drugs (1-2%), eg. Sulphamethoxazole-trimethoprim, Azathioprine, NSAIDs, Diuretic, valproate
46
Neoplastic, congenital and genetic causes of acute pancreatitis
→ Neoplasm: pancreatic or ampullary tumour → Congenital: pancreas divisum, choledochocele type V → Genetics, eg. cystic fibrosis, PRSS1, SPINK1 and other mutations
47
Pathogenesis of acute pancreatitis
Inciting event = acinar cell injury leading to premature trypsinogen activation within acina + inflammation → Ductal obstruction (eg. gallstones) → interstitial oedema → impaired blood flow → acinar cell injury → Acinar cell injury (eg. alcohol, drugs, hyperCa) → ↑inappropriate intracellular release + activation of enzymes → Defective intracellular transport
48
Acute Pancreatitis: Local histological changes Systemic responses Progression
Early local changes: → Autodigestion of pancreatic tissues, fat necrosis → Microcirculatory injury: interstitial oedema and ischaemia-reperfusion injury → Inflammatory changes (esp NFκB activation) with cytokine release and leukocyte activation Systemic responses: SIRS due to systemic spillage of cytokines and activated pancreatic enzymes Bacterial translocation: systemic hypovolemia + gut A-V shunting, systemic sepsis with endotoxaemia Progression: Necrotizing pancreatitis: persistent ampullary obstruction + hypoperfusion
49
Acute pancreatitis Clinical presentation (OPQRST) + associated S/S
Severe epigastric pain that radiates to the back → Acute onset, of increasing intensity over 15-60min, lasts for several hours to days → Severe, constant, boring sensation that radiates to the back (50%) → Usually localized to upper abdomen, occ. in RUQ or rarely LUQ → Usually ↑ by movement and ↓by sitting up and leading forward → Initially a/w very little peritoneal signs Associated S/S □ Nausea and vomiting (90%) □ Fever □ Features of retroperitoneal haemorrhage
50
List Features of retroperitoneal haemorrhage in haemorrhagic pancreatitis
→ Cullen’s sign: bruises of periumbilical region → Grey Turner’s sign: bruises of flank region → Fox’s sign: bruises over inguinal ligament
51
Complications and S/S of acute pancreatitis
Diffuse peritonitis Hypovolaemia ± shock Dyspnoea: due to pleural effusion or ARDS Palpable pseudocyst Pancreatic ascites when fluid leaks from disrupted pancreatic duct into peritoneal cavity Splanchnic venous thrombosis Abdominal compartment syndrome due to tissue oedema, ascites, ileus
52
Diagnostic criteria of acute pancreatitis
≥2 out of 3 of (Revised Atlanta classification, 2013) □ Epigastric pain: acute onset of persistent, severe epigastric pain often radiating to the back □ ↑serum lipase/amylase to ≥3× ULN □ Characteristic imaging finding of acute pancreatitis on contrast CT, MRI or trans-abdominal USG
53
First-line investigations of acute pancreatitis
LFT: high ALT for gallstone pancreatitis, high bilirubin for gallstone at ampulla Abdominal ultrasound: Swollen pancreas, Peripancreatic fluid anechoic collection Endoscopic US: occult biliary stones ERCP for gallstone clearance Serum amylase Serum Ca, lipids → hyperCa, hyperlipidaemia CXR: mainly to r/o PPU, complications like pleural effusions or ARDS AXR: focal ileus with sentinel loop sign, or calcification of chronic pancreatitis Contrast CT to confirm diagnosis and find cause later
54
Indications for additional Contrast CT for acute pancreatitis
TAUS shows: → Focal or diffuse enlargement with homogeneous enhancement → Peripancreatic fat stranding → ± complications: necrosis, abscesses...etc
55
D/dx acute pancreatitis
Peptic ulcer disease Perforated Peptic ulcer Cholangitis, CBD gallstones Cholecystitis Intestinal obstruction Mesenteric ischemia
56
Severity score for acute pancreatitis
``` Glasgow’s criteria: ≥3 within first 48h indicates a severe attack □ PaO2: <8kPa = 60mmHg □ Age: >55 years □ Neutrophils: >15× 109/L □ Calcium: <2mmol/L □ Renal: urea >16mmol/L □ Enzymes: LDH >600IU/L or AST/ALT >200IU/L □ Albumin: <32g/L □ Sugar: glucose >10mmol/L ```
57
Outline the Atlanta classification for severity/ complications of acute pancreatitis
58
Severity/ Mortality score for acute pancreatitis
Mortality: 0-2% (0-2), 15% (3-4), 50% (5-6), 70-90% (≥7)
59
Supportive treatment for mild acute pancreatitis
1. IV fluid resuscitation 2. NPO + NGT aspiration if persistent vomiting, significant gastroparesis or ileus 3. Enteral feeding/ Parenteral feeding 4. Analgesics: Opioids: preferred, usually fentanyl, hydromorphone, tramadol, NOT MORPHINE (tighten sphincter of Oddi) 5. Antibiotics: therapeutic (NOT prophylactic) for infected necrosis 6. Serial contrast CT
60
Definitive treatment for severe acute pancreatitis
1. Infected necrosis: empirical antibiotics and percutaneous drainage/ endoscopic debridement 2. Bowel ischemia, acute necrotizing cholecystitis, ongoing bleed: surgical debridement/ necrosectomy 2. ERCP for biliary stone removal 3. Manage complications or organ failures
61
Chronic pancreatitis Pathogenesis Causes
Chronic pancreatitis: prolonged inflammation of pancreas a/w irreversible destruction of exocrine parenchyma, fibrosis and, in late stages, destruction of endocrine parenchyma ``` Aetiology: NOT gallstones - Alcohol - Toxic-metabolic: tobacco smoking, hyperCa, chronic renal failure - Severe, recurrent acute pancreatitis - Autoimmune: IgG4-related disease - Ductal obstruction (genetics and congenital...etc) ```
62
Chronic pancreatitis Clinical presentation
Abdominal pain - Epigastric with radiation to back - Worse post-prandial - Improve by sitting forward, drink alcohol Pancreatic exocrine insufficiency (90% exocrine mass loss) - Fat malabsorption: steatorrhoea ± vitamin A, D, E, K, B12 malabsorption - Protein malabsorption Pancreatic endocrine insufficiency, i.e. secondary diabetes mellitus Loss of weight: 2o to combination of anorexia, avoidance of food (post-prandial discomfort) and DM
63
Chronic pancreatitis Physical findings
Weight loss: thin, malnourished Epigastric tenderness Enlarged pancreas: occ. palpable, esp in thin pt (d/dx pseudocyst) Erythema ab igne: skin pigmentation over abdomen/back
64
First-line investigations for chronic pancreatitis
Radiological diagnosis: usually 1st line: Plain AXR: calcifications in pancreatic duct USG: ductal dilatation, parenchymal changes with ↑echogenicity and irregular gland contour CT: ductal dilatation, calcification, pseudocysts EUS ERCP: current gold-standard: Characteristic chain-of-lakes appearance of ductal anatomy ``` Biochemical: Faecal pancreatic elastase Secretin stimulation test 72h fecal fat collection OGTT for endocrine insufficiency ```
65
Major ddx of chronic pancreatitis
CA pancreas □ Clinical features: older age, absence of Hx of alcohol use, weight loss, protracted flare of Sx, significant constitutional symptoms
66
Treatment plan of chronic pancreatitis
1. Lifestyle modifications: Abstinence from alcohol Small low-fat meals with hydration/ fat-restricitons Cessation of smoking 2. Pain relief: Analgesics: opioids, low-dose amitriptyline + NSAIDs 3. Oral pancreatic enzyme supplements, eg. pancreatin 4. Endoscopic dilatation of ductal strictures/ Surgical drainage/ resection e.g. Whipple’s procedure 5. Medium-chain triglycerides (MCTs) + Vitamin supplementation: vitamin D, calcium 6. Insulin for secondary DM
67
Complications of chronic pancreatitis
Pseudocyst formation (10%) CBD/duodenal obstruction (5-10%): inflammation and fibrosis of HOP or pseudocyst Pancreatic ascites and pleural effusion/ fistulation into peritoneal/pleural cavity Splenic vein thrombosis (11%) CA pancreas
68
Ddx perforated PU
→ SB: perforated diverticulum, SB ulcer (eg. CMV), tumours (lymphoma (most common), CA lung and breast) → LB: closed loop obstruction, diverticulum → Acute appendicitis: NO GAS because of obstruction → Others: colonoscopy-related, FB-related